Five years have elapsed since the advent https://starmedpharmacy.com/ gained over this period, it is useful delivery, efficacy, and dosage for the wide variety of migraine presentations.
There an the US market. They are — in the order of their introduction Available dosages and manufacturers are listed in Table 1.
Available in Europe, and possibly soon in the 80mg tablets from Pfizer.
With the notable exception o injectable, which have an increased percentage of efficacy over any pill, the efficacy rates between all of the pills — comparing dose to dose — are roughly the same with only minor variation. In general, when one combines most of the studies done o comparing equal doses of the oral agents, they all seem to work in the 40 to 60 with statistically equal efficacy, there does seem to be a variance in the individual preference for
The class contains three categories: the ultra fast or immediate acting, the fast acting, and the slow acting/long lasting (see Table 2).
injectable is the only ultra-fast and has a We now have a wide range of treatment options for the many presentations of migraine injectable is for the migraine that needs to be stopped as quickly and completely a
Following are discussions of clinical observations for each of the s identified above.
has the advantage of coming with the most widely diverse dosage forms and delivery systems. The nasal spray and the injectable offer alternatives for the nauseated or migraine patient with actual emesis. There is certainly no doubt that the subcutaneous form of that works the quickest and is most generally effective. It has a 70% efficacy at a one hour response rate compared to a two-hour response rate for all the others. Another advantage is that you can move between the dosage forms. There is allowance for individual migraine variation between individual patients. For instance, one can use an tablet for mild headaches or headaches having slow onset with the option of switching to an nasal spray if the headache onset accelerates or has more nausea associated with injectable can be used if the headache is coming on rapidly, the patient is vomiting, or if a break-through headache occurs with tablet pill or nasal spray is used as a option of a follow-up in the event that the headache does not respond or worsens. Note however that the FDA ha injectable with any o so not an option was used as the starting dose. The only option in this case is to utilize medication outside of the include side effects and recurrence r